Gotham Asset Management, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$684,686
-10.6%
22,317
+16.8%
0.01%
-17.6%
Q2 2023$765,898
-38.4%
19,114
-37.2%
0.02%
-43.3%
Q1 2023$1,242,624
+360.2%
30,449
+499.5%
0.03%
+275.0%
Q3 2022$270,000
+16.4%
5,079
+27.5%
0.01%
+14.3%
Q2 2022$232,000
-53.3%
3,982
-38.8%
0.01%
-53.3%
Q1 2022$497,000
-66.4%
6,508
-73.5%
0.02%
-68.8%
Q4 2021$1,479,000
+29.6%
24,574
+20.6%
0.05%
+4.3%
Q3 2021$1,141,000
+148.0%
20,376
+168.7%
0.05%
+142.1%
Q2 2021$460,000
-9.8%
7,582
+4.1%
0.02%
-17.4%
Q1 2021$510,000
-29.0%
7,281
-39.4%
0.02%
-4.2%
Q4 2020$718,000
+0.6%
12,007
+1.2%
0.02%
+4.3%
Q3 2020$714,0000.0%11,870
-12.7%
0.02%
+9.5%
Q2 2020$714,000
-64.7%
13,602
-77.4%
0.02%
-62.5%
Q1 2020$2,020,000
+55.6%
60,239
+110.3%
0.06%
+133.3%
Q4 2019$1,298,000
-33.0%
28,646
-43.7%
0.02%
-29.4%
Q3 2019$1,938,000
+2.8%
50,916
+17.5%
0.03%
+13.3%
Q2 2019$1,885,000
+504.2%
43,345
+428.1%
0.03%
+500.0%
Q1 2019$312,000
-62.3%
8,208
-11.9%
0.01%
-16.7%
Q1 2015$828,000
+23.0%
9,319
+34.2%
0.01%
-14.3%
Q3 2014$673,000
-22.7%
6,946
-26.8%
0.01%
-36.4%
Q2 2014$871,0009,4860.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders